Evaluating the hepatitis B vaccination impact in the Republic of Moldova: A nationwide representative serosurvey of children born in 2013

Hepatitis B Seroprevalence
DOI: 10.1016/j.ijregi.2023.11.003 Publication Date: 2023-11-08T12:59:25Z
ABSTRACT
The WHO European Region set targets for the control of hepatitis B through immunization, including prevalence surface antigen (HBsAg) at ≤0.5% in vaccinated cohorts. Republic Moldova implemented universal vaccination since 1995. We conducted a nationwide representative serosurvey to estimate HBsAg seroprevalence children born 2013 validate targets.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (2)